Yuki Gosei Kogyo Co., Ltd.
[Organic Synthesis Pharmaceuticals] Share Buyback and Introduction of Compensation System | July 2026
Organic Synthesis Pharmaceuticals plans to sell 25,325 shares of common stock at 346 yen per share on August 20, 2026, and introduce a new compensation system for directors and executive officers.
Key Figures
- Number of Shares Sold: 25,325 shares
- Total Sale Price: 8,762,450 yen
- Price per Share: 346 yen
AI要約
Overview of Share Buyback
On August 20, 2026, Organic Synthesis Pharmaceuticals will sell 25,325 shares of common stock at 346 yen per share as part of its Restricted Stock Compensation Plan. The purpose of the sale is to enhance corporate value sustainably and provide incentives to officers. The shares to be sold will be managed in a dedicated account by a financial instruments business operator. The total sale amount is 8,762,450 yen, set based on the market stock price.
Background and Details of the Compensation System Introduction
Simultaneously, the company will introduce a Restricted Stock Compensation Plan for eligible directors and executive officers, with transfer restrictions imposed for a certain period and provisions for free acquisition upon retirement. The system will commence on August 20, 2026, with transfer restrictions lifted at retirement, and the shares will be acquired free of charge. This aims to promote officers' commitment to long-term corporate value enhancement.
Organic Synthesis Pharmaceuticals Inc.
Company overview · Stock price · Financial data · All IR
